Media coverage about Markel (NYSE:MKL) has trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Markel earned a news impact score of 0.22 on Accern’s scale. Accern also gave media headlines about the insurance provider an impact score of 45.8275848712581 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Here are some of the news stories that may have effected Accern Sentiment’s rankings:
Shares of Markel (MKL) traded down $31.14 during trading on Friday, reaching $1,117.37. 54,268 shares of the company’s stock traded hands, compared to its average volume of 40,568. Markel has a twelve month low of $909.00 and a twelve month high of $1,157.30. The stock has a market capitalization of $15,954.99, a PE ratio of 248.30 and a beta of 0.95. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.55 and a quick ratio of 0.55.
A number of brokerages have issued reports on MKL. Zacks Investment Research raised shares of Markel from a “hold” rating to a “buy” rating and set a $1,238.00 price target on the stock in a report on Friday, January 12th. Boenning Scattergood reaffirmed a “buy” rating on shares of Markel in a research report on Thursday, October 26th. Finally, SunTrust Banks reissued a “hold” rating and set a $1,100.00 price target on shares of Markel in a research report on Friday, October 27th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $1,109.50.
In related news, insider Alan I. Kirshner sold 100 shares of the business’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $1,133.50, for a total transaction of $113,350.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Vice Chairman Steven A. Markel sold 200 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $1,143.47, for a total transaction of $228,694.00. Following the sale, the insider now owns 106,360 shares of the company’s stock, valued at $121,619,469.20. The disclosure for this sale can be found here. Insiders sold 2,338 shares of company stock valued at $2,587,732 over the last quarter. Company insiders own 2.53% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece of content was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/03/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-markel-mkl-share-price.html.
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.